(Q70541113)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Antitumor effects of recombinant interleukin-6 expressed in eukaryotic cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

A Eisenthal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

H Kashtan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

M Rabau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

V Ramakrishna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

S Chaitchik

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Y Skornick

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

101-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01754409

12 October 2019

exact match

0 references

cites work

The in vivo anti-tumor effect of human recombinant interleukin-6.

1 reference

12 December 2020

In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

1 reference

12 December 2020

Antitumor activity of recombinant interleukin 6 in mice

1 reference

12 December 2020

Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1)

1 reference

12 December 2020

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

12 December 2020

B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes

1 reference

12 December 2020

Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSF.

1 reference

12 December 2020

Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli

1 reference

12 December 2020

Characterization of IL-2-induced murine cells which exhibit ADCC activity

1 reference

12 December 2020

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

12 December 2020

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

12 December 2020

Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2

1 reference

12 December 2020

Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody

1 reference

12 December 2020

Systemic induction of cells mediating antibody-dependent cellular cytotoxicity following administration of interleukin 2

1 reference

12 December 2020

Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines

1 reference

12 December 2020

B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes

1 reference

12 December 2020

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

1 reference

12 December 2020

Monoclonal antibodies for affinity purification of IL-6/IFN- beta 2 and for neutralization of HGF activity

1 reference

12 December 2020

Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo

1 reference

12 December 2020

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1 reference

12 December 2020

A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2

1 reference

12 December 2020

Mediation of mouse natural cytotoxic activity by tumour necrosis factor

1 reference

12 December 2020

Interleukin 6 is the principal cytolytic T lymphocyte differentiation factor for thymocytes in human leukocyte conditioned medium

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells

1 reference

12 December 2020

Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical

1 reference

12 December 2020

Characterization of a novel murine T cell-activating factor

1 reference

12 December 2020

Serologic Identification of Multiple Tumor-Associated Antigens on Murine Sarcomas

1 reference

12 December 2020

Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines

1 reference

12 December 2020

The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha

1 reference

12 December 2020

Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro

1 reference

12 December 2020

IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells

1 reference

12 December 2020

Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells

1 reference

12 December 2020

Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma

1 reference

12 December 2020

Interleukin-6 enhances the induction of human lymphokine-activated killer cells

1 reference

12 December 2020

Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes

1 reference

12 December 2020

Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines

1 reference

12 December 2020

A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex

1 reference

12 December 2020

IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01754409

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8425207%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference